Core Viewpoint - The company has recently completed the acquisition of a property in Irvine, California, for a total cost of $4.365 million and established a wholly-owned subsidiary in Colorado to facilitate its operations in North America related to stablecoins and intellectual property securitization in the medical and innovative pharmaceutical sectors [1] Group 1: Company Developments - The company acquired a property in Orange County, California, for $4.365 million [1] - A wholly-owned subsidiary, ETHKBANK Inc., was registered in Colorado to support the company's North American market activities [1] Group 2: Market Performance - As of October 13, 2025, the company's stock closed at HKD 8.88, down 4.62%, with a trading volume of 1.641 million shares and a turnover of HKD 14.6533 million [1] - The company has a market capitalization of HKD 15.069 billion, ranking second in the pharmaceutical commercial sector [1] Group 3: Financial Metrics - Key financial metrics for the company compared to the industry average are as follows: - ROE: 4.69% (industry average: 0.84%), ranking 6th [1] - Market capitalization: HKD 15.069 billion (industry average: HKD 5.112 billion), ranking 2nd [1] - Revenue: HKD 3.079 billion (industry average: HKD 78.621 billion), ranking 4th [1] - Net profit margin: 3.02% (industry average: 3.11%), ranking 4th [1] - Gross profit margin: 22.02% (industry average: 24.95%), ranking 5th [1] - Debt ratio: 42.78% (industry average: 41.64%), ranking 6th [1]
华检医疗(01931.HK)收购美国物业及设立美国附属公司ETHK BANK 于美国推进稳定币及知识产权证券化新征程